Video Experimental Relacionado

Updated: May 5, 2026

Fast Micro-iontophoresis of Glutamate and GABA: A Useful Tool to Investigate Synaptic Integration

Fast Micro-iontophoresis of Glutamate and GABA: A Useful Tool to Investigate Synaptic Integration

Published on: August 1, 2013

Modulación directa del primado de las vesículas sinápticas por la activación del receptor GABA (((B) en una sinapsis

Takeshi Sakaba¹, Erwin Neher

¹Department of Membrane Biophysics, Max Planck Institute for Biophysical Chemistry, Göttingen 37077, Germany.

|August 15, 2003

Resumen

La señalización de la proteína G, al igual que a través de los receptores GABA, retrasa el reclutamiento de las vesículas sinápticas al reducir la AMP cíclica (cAMP). Esto afecta la dinámica de la red neuronal mediante la modulación de la liberación de neurotransmisores.

Área de la Ciencia:

La neurociencia es la neurociencia.
Biología Molecular Biología Molecular
La señalización celular.

Sus antecedentes:

Las cascadas de proteína G y calcio regulan la liberación de neurotransmisores.
El influjo presináptico de calcio es un objetivo clave para modular la liberación.

Objetivo del estudio:

Investigar el papel de la señalización de la proteína G en el reclutamiento de las vesículas sinápticas.
Elucidar el mecanismo por el cual la activación del receptor GABA (((B) afecta la plasticidad sináptica.

Principales métodos:

Estudió las vías de señalización mediadas por la proteína G.
Se examinaron los efectos de la activación del receptor GABA (B) sobre la dinámica de las vesículas sinápticas.
Investigó el papel de la AMP cíclica (cAMP) y el calcio en el primado de las vesículas.

Principales resultados:

La señalización de la proteína G, a través de los receptores GABA, retrasa el reclutamiento de vesículas sinápticas durante la actividad sostenida y la depresión a corto plazo.
Esta retardación está mediada por una disminución de la cAMP, que inhibe el efecto estimulante del calcio en el reclutamiento de las vesículas.
cAMP y calcio/calmodulina cooperan para mejorar el primado de las vesículas.

Conclusiones:

La señalización de la proteína G modula diferencialmente la inhibición presináptica y la recuperación dependiente del calcio de la depresión sináptica.
Estos hallazgos tienen implicaciones para la comprensión de la dinámica de las redes neuronales y la plasticidad sináptica.

Más Videos Relacionados

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors

Published on: November 14, 2014

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

Videos de Conceptos Relacionados

Fusion of Secretory Vesicles with the Plasma Membrane

Fusion of Secretory Vesicles with the Plasma Membrane

Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...

Chemical Synapses

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...

Chemical Synapses

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...